| Featured Story | By Annalee Armstrong Novartis already bought into optogenetic gene therapy technology last year, but the Swiss Pharma wants more. Enter Arctos Medical, which will now join Novartis with its gene therapy program for vision loss. read more |
| |
|---|
|
Top Stories By Emmy Lucas Jeffrey Stafford and his team of industry veterans have seen their biotechs go on to be acquired by the likes of Genentech, Bristol Myers Squibb and Celgene. Now, the collective is ready for its next venture: launching RNA biotech 858 Therapeutics with a $60 million series A fundraising. read more By Nick Paul Taylor Maybe primary endpoints matter after all. Days after dismissing the importance of a midphase flop, Aerie Pharmaceuticals CEO Vicente Anido has left the company, leaving an interim leader to pursue what he claimed was “a clear path toward approval.” read more Sponsored By: RBC Capital Markets Gene editing is at the new frontier of biotech innovation, driving capital investments and momentum within the IPO market. Learn more. read more By Nick Paul Taylor BioMed Realty is already a major force in the U.K. life sciences property game, with AstraZeneca and Illumina among the companies to occupy its sites in and around Cambridge. Now, the Blackstone company is set to invest a further £850 million ($1.2 billion) to double the size of its portfolio. read more Sponsored by: IPM.ai Rare diseases demand a modern recruitment approach grounded in uncovering the ideal, medically-eligible patient population with the highest propensity for study enrollment and retention. read more By Amirah Al Idrus As MiroBio gears up for its first clinical trial, the autoimmune biotech is getting a new CEO: Carolin Barth, M.D., joins after a 17-year run at Novartis, where she most recently led commercial and pipeline strategy for cell and gene therapies. read more By Kyle LaHucik Boehringer Ingelheim is acquiring Abexxa Biologics to continue building out its pipeline in immuno-oncology and cancer treatments. The German Big Pharma had initially seeded the Arlington, Texas-based biotech in 2016 and provided shared collaboration space. read more By Andrea Park Soon enough, the iPhone in your pocket could automatically detect mental health issues like depression, anxiety and cognitive decline—all based on the daily activity data already gathered by the device. read more By Kevin Dunleavy Pfizer and BioNTech reported that their COVID-19 vaccine is safe and generated a strong response in kids aged 5 to 11. The smaller dosage shot (10 micrograms) provided comparable antibody responses the the 30 microgram dose given to 16- to 25-year-olds. The companies will apply for EUA "as soon as possible." read more By Robert King Hospital groups push back on CMS proposal to raise penalties for failing to publish their prices, arguing health systems have prioritized fighting COVID-19 over complying with a new price transparency rule. read more By Beth Snyder Bulik True or false: Pharmaceutical companies are required to send drug ads to FDA for approval before they're used. It’s false—but you'd already would know that if you took the FDA’s new interactive quiz to help promote its Bad Ad program. read more By Joseph Keenan Verrica Pharmaceuticals, which is seeking approval for a medication to treat skin diseases, said the FDA issued a complete response letter that outlines problems at a CMO facility being used to manufacture the treatment. read more |  | Download the AppNote to learn about Thermo Fisher Scientific’s GMP-compliant, semiautomated manufacturing platform, which when used with Gibco CTS reagents, protocols, and analytics can result in consistent, efficacious CAR T cell production. Download Now. |
Resources Sponsored By: Unlearn AI Read Unlearn’s whitepaper to learn about how novel trial designs with Digital Twins enable more efficient clinical trials, with higher power and smaller required sample sizes. Sponsored by: Patheon by Thermo Fisher Scientific Choose the right AAV platform for your viral vector-based therapy Sponsored by: XIFIN inc. Download the Value of Precision Medicine Informatics (PMI) Initiatives report to learn about the technology, data types, and the value derived from more than 100 PMI initiatives. Sponsored by: EVERSANA Today’s economics do not allow manufactures to keep making decisions in an antiquated way. They need to challenge tradition & deliver faster, cheaper, successful launches. Learn how. Sponsored by: Thermo Fisher Scientific Thermo Fisher Scientific introduces a new NK cell culture medium designed to support feeder-free, high-yield growth for cell therapy applications. Sponsored by: Cascade Chemistry by Aceto Read four customer success stories and four success factors that helped move pharmaceutical customers of Cascade Chemistry by Aceto quickly and effectively to clinic with trial-ready APIs. Sponsored by: Box Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Catalent Get insights on key considerations for a successful tech transfer process for manufacturing a biologic drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent. | 
